Prudential Financial Inc Eagle Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$15.21 - $22.88 $535,392 - $805,376	35,200 Added 54.93%	99,284 $1.57 Million
Q2 2023 Aug 11, 2023	BUY	$17.74 - $31.87 $225,404 - $404,940	12,706 Added 24.73%	64,084 $1.25 Million
Q1 2023 May 12, 2023	SELL	$25.06 - $34.09 $411,234 - $559,416	-16,410 Reduced 24.21%	51,378 $1.46 Million
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $60,201 - $95,845	2,410 Added 3.69%	67,788 $0
Q3 2022 Nov 04, 2022	SELL	$26.42 - $47.12 $152,179 - $271,411	-5,760 Reduced 8.1%	65,378 $1.73 Million
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $1.98 Million - $2.47 Million	-48,035 Reduced 40.31%	71,138 $3.16 Million
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $738,378 - $871,213	-16,563 Reduced 12.2%	119,173 $5.9 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $2.39 Million - $2.97 Million	-52,266 Reduced 27.8%	135,736 $6.91 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $470,786 - $599,690	10,751 Added 6.07%	188,002 $10.5 Million
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $1.27 Million - $1.53 Million	-34,492 Reduced 16.29%	177,251 $7.59 Million
Q1 2021 May 12, 2021	SELL	$40.32 - $50.97 $984,412 - $1.24 Million	-24,415 Reduced 10.34%	211,743 $8.84 Million
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $9.83 Million - $12.1 Million	235,672 Added 48492.18%	236,158 $11 Million
Q3 2020 Aug 05, 2021	SELL	$37.02 - $51.28 $8.16 Million - $11.3 Million	-220,355 Reduced 99.78%	486 $21,000
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $8.16 Million - $11.3 Million	220,322 Added 42451.25%	220,841 $9.38 Million
Q2 2020 Aug 05, 2021	SELL	$43.24 - $55.02 $9.19 Million - $11.7 Million	-212,526 Reduced 99.76%	519 $25,000
Q2 2020 Aug 12, 2020	BUY	$43.24 - $55.02 $9.19 Million - $11.7 Million	212,544 Added 42423.95%	213,045 $10.2 Million
Q1 2020 Aug 05, 2021	SELL	$34.37 - $60.07 $4 Million - $6.99 Million	-116,419 Reduced 99.57%	501 $23,000
Q1 2020 May 12, 2020	BUY	$34.37 - $60.07 $4 Million - $7 Million	116,457 Added 25152.7%	116,920 $5.38 Million
Q4 2019 Aug 05, 2021	SELL	$54.32 - $64.31 $6.45 Million - $7.64 Million	-118,768 Reduced 99.61%	463 $28,000
Q4 2019 Feb 11, 2020	BUY	$54.32 - $64.31 $6.45 Million - $7.64 Million	118,823 Added 29123.28%	119,231 $7.16 Million
Q3 2019 Aug 05, 2021	SELL	$53.25 - $59.98 $4.74 Million - $5.34 Million	-88,964 Reduced 99.54%	408 $23,000
Q3 2019 Nov 13, 2019	BUY	$53.25 - $59.98 $4.74 Million - $5.34 Million	88,990 Added 23295.81%	89,372 $5.06 Million
Q2 2019 Aug 05, 2021	SELL	$46.61 - $58.45 $2.69 Million - $3.38 Million	-57,759 Reduced 99.34%	382 $21,000
Q2 2019 Aug 08, 2019	BUY	$46.61 - $58.45 $2.69 Million - $3.38 Million	57,806 Added 17255.52%	58,141 $0
Q1 2019 Aug 05, 2021	SELL	$38.66 - $51.82 $2.09 Million - $2.8 Million	-54,036 Reduced 99.38%	335 $17,000
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $2.1 Million - $2.82 Million	54,329 Added 129354.76%	54,371 $0
Q4 2018 Aug 05, 2021	SELL	$36.72 - $67.73 $1.2 Million - $2.22 Million	-32,813 Reduced 99.87%	42 $2,000
Q4 2018 Feb 07, 2019	BUY	$36.72 - $67.73 $1.21 Million - $2.22 Million	32,828 Added 121585.19%	32,855 $1.32 Million
Q3 2018 Sep 01, 2021	SELL	$66.65 - $83.86 $1.68 Million - $2.12 Million	-25,238 Reduced 99.89%	27 $2,000
Q3 2018 Nov 07, 2018	BUY	$66.65 - $83.86 $1.68 Million - $2.12 Million	25,249 Added 157806.25%	25,265 $0
Q2 2018 Sep 01, 2021	SELL	$51.25 - $76.62 $863,870 - $1.29 Million	-16,856 Reduced 99.91%	16 $1,000
Q2 2018 Aug 13, 2018	SELL	$51.25 - $76.62 $9.17 Million - $13.7 Million	-179,010 Reduced 91.39%	16,872 $0
Q1 2018 May 04, 2018	SELL	$52.16 - $66.86 $10.8 Million - $13.8 Million	-206,240 Reduced 51.29%	195,882 $0
Q4 2017 Feb 13, 2018	BUY	$49.6 - $60.87 $8.93 Million - $11 Million	180,050 Added 81.08%	402,122 $21.5 Million
Q3 2017 Nov 02, 2017	BUY	$46.62 - $60.36 $10.4 Million - $13.4 Million	222,072	222,072 $13.2 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account